Objectives <p>Constructing a multi-task global decision support system based on preoperative enhanced CT features to predict the mismatch repair (MMR) status, T stage, and pathological risk factors (e.g., histological differentiation, lymphovascular invasion) for patients with non-metastatic colon cancer.</p> Methods <p>372 eligible non-metastatic colon cancer (NMCC) participants (training cohort: <i>n</i> = 260; testing cohort: <i>n</i> = 112) were enrolled from two institutions. The 34 features (imaging features: <i>n</i> = 27; clinical features: <i>n</i> = 7) were subjected to feature selection using LASSO, Boruta, ReliefF, mRMR, and XGBoost-RFE, respectively. In each of the three categories—MMR, pT staging, and pathological risk factors—four features were selected to construct the total feature set. Subsequently, the multitask model was built with 14 machine learning algorithms. The predictive performance of the machine model was evaluated using the area under the receiver operating characteristic curve (AUC).</p> Results <p>The final feature set for constructing the model is based on the mRMR feature screening method. For the final MMR classification, pT staging, and pathological risk factors, SVC, Bernoulli NB, and Decision Tree algorithm were selected respectively, with AUC scores of 0.80 [95% CI 0.71–0.89], 0.82 [95% CI 0.71–0.94], and 0.85 [95% CI 0.77–0.93] on the test set. Furthermore, a direct multiclass model constructed using the total feature set resulted in an average AUC of 0.77 across four management plans in the test set.</p> Conclusion <p>The multi-task machine learning model proposed in this study enables non-invasive and precise preoperative stratification of patients with NMCC based on MMR status, pT stage, and pathological risk factors. This predictive tool demonstrates significant potential in facilitating preoperative risk stratification and guiding individualized therapeutic strategies.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Multitask radioclinical decision stratification in non-metastatic colon cancer: integrating MMR status, pT staging, and high-risk pathological factors

  • Ruidan Yang,
  • Jiong Liu,
  • Lihong Li,
  • Yinfei Fan,
  • Yue Shu,
  • Wenzheng Wu,
  • Jian Shu

摘要

Objectives

Constructing a multi-task global decision support system based on preoperative enhanced CT features to predict the mismatch repair (MMR) status, T stage, and pathological risk factors (e.g., histological differentiation, lymphovascular invasion) for patients with non-metastatic colon cancer.

Methods

372 eligible non-metastatic colon cancer (NMCC) participants (training cohort: n = 260; testing cohort: n = 112) were enrolled from two institutions. The 34 features (imaging features: n = 27; clinical features: n = 7) were subjected to feature selection using LASSO, Boruta, ReliefF, mRMR, and XGBoost-RFE, respectively. In each of the three categories—MMR, pT staging, and pathological risk factors—four features were selected to construct the total feature set. Subsequently, the multitask model was built with 14 machine learning algorithms. The predictive performance of the machine model was evaluated using the area under the receiver operating characteristic curve (AUC).

Results

The final feature set for constructing the model is based on the mRMR feature screening method. For the final MMR classification, pT staging, and pathological risk factors, SVC, Bernoulli NB, and Decision Tree algorithm were selected respectively, with AUC scores of 0.80 [95% CI 0.71–0.89], 0.82 [95% CI 0.71–0.94], and 0.85 [95% CI 0.77–0.93] on the test set. Furthermore, a direct multiclass model constructed using the total feature set resulted in an average AUC of 0.77 across four management plans in the test set.

Conclusion

The multi-task machine learning model proposed in this study enables non-invasive and precise preoperative stratification of patients with NMCC based on MMR status, pT stage, and pathological risk factors. This predictive tool demonstrates significant potential in facilitating preoperative risk stratification and guiding individualized therapeutic strategies.